Vertex Pharmaceuticals INC / MA ceo salary
Reshma Kewalramani, CEO and President (EVP & Chief Medical Officer through March 31 2020) of VERTEX PHARMACEUTICALS INC / MA (VRTX), received $9,111,359 ($9.1M) in total compensation for FY2020. Stock awards of $5,250,411 were the largest component. Figures come from VERTEX PHARMACEUTICALS INC / MA's DEF 14A filed 8 Apr 2021 (accession 0001308179-21-000196).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001308179-21-000196). These figures come from VERTEX PHARMACEUTICALS INC / MA's DEF 14A filed 8 Apr 2021 (accession 0001308179-21-000196).
| Component | Amount |
|---|---|
| Salary | $1,097,308 |
| Stock awards | $5,250,411 |
| Cash incentive | $2,723,292 |
| Other | $40,348 |
| Total | $9,111,359 |
FAQ
See also: VRTX ticker page